Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Published 24/01/2024, 15:12
Updated 24/01/2024, 18:11
© Reuters.

By Abigail Summerville

(Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon (LON:HLN) Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Yellow Wood has prevailed in an auction for ChapStick that Haleon had launched, hoping to fetch about $600 million, the sources said. Yellow Wood's offer came in lower than what Haleon was seeking, the sources added.

The two sides are close to reaching a compromise on a valuation, the sources said. If they succeed, a deal could be inked in the next few days, the sources added. It is possible that the discussions end without an agreement.

The sources asked not to be identified because the matter is confidential. Haleon and Yellow Wood declined to comment.

A deal for ChapStick would come on the heels of Yellow Wood's acquisitions of Suave and Elida Beauty, a portfolio of personal care brands that includes Q-Tips, Brut, Caress, Timotei and Tigi, from Unilever (LON:ULVR) last year. Based in Boston, Yellow Wood focuses on deals in the consumer sector.

GSK spun Haleon out into an independently listed company in London in 2022. Haleon, which has a market value of $29 billion, has been pruning its portfolio to focus on its more popular consumer health brands, such as Advil, Tums and Centrum.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.